His primary scientific interests are in Cell biology, Molecular biology, Internal medicine, Cancer research and Pathology. His studies deal with areas such as Receptor, Cytotoxic T cell and Immunology as well as Cell biology. His Molecular biology research incorporates elements of Fibronectin, Epstein–Barr virus, Transcriptional regulation, Transfection and MUC1.
Luigi Frati combines subjects such as Endocrinology, Oncology and Drug resistance with his study of Internal medicine. His Cancer research research is multidisciplinary, incorporating elements of Apoptosis, Downregulation and upregulation and T cell. His research in Pathology intersects with topics in Gastroenterology, Cell and Gene expression.
Luigi Frati spends much of his time researching Cell biology, Internal medicine, Molecular biology, Cancer research and Immunology. The Cell biology study combines topics in areas such as T cell and Cellular differentiation. His Internal medicine research incorporates themes from Gastroenterology, Endocrinology, Oncology and Pathology.
His Oncology research integrates issues from Breast cancer and Ovarian cancer. His biological study deals with issues like Antigen, which deal with fields such as Monoclonal antibody. His Cancer research study combines topics in areas such as Cell culture, Cancer and Apoptosis.
His primary areas of investigation include Internal medicine, Cancer research, Oncology, Pathology and Cell biology. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Endocrinology. His Cancer research research incorporates themes from Cell culture, Apoptosis, Programmed cell death, Bortezomib and Receptor.
His Pathology research includes themes of Immunoassay, Radioimmunoassay, Tumor marker and Serum samples. The concepts of his Cell biology study are interwoven with issues in Molecular biology and Biochemistry. Luigi Frati combines subjects such as Downregulation and upregulation and Antigen with his study of Molecular biology.
Luigi Frati mainly focuses on Cancer research, Internal medicine, Oncology, Pathology and Downregulation and upregulation. His Cancer research research incorporates elements of T cell, Apoptosis, Programmed cell death, Bortezomib and Primary effusion lymphoma. Luigi Frati interconnects Endocrinology and Drug resistance in the investigation of issues within Internal medicine.
His work carried out in the field of Pathology brings together such families of science as Adipose tissue and Hyaluronic acid. His research in Downregulation and upregulation intersects with topics in Epstein–Barr virus, Receptor, Molecular biology, microRNA and Phosphorylation. His study on Notch signaling pathway is often connected to HDAC1 as part of broader study in Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart
Elisa Messina;Luciana De Angelis;Giacomo Frati;Stefania Morrone.
Circulation Research (2004)
Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer
P. Gazzaniga;A. Gradilone;L. Giuliani;O. Gandini.
Annals of Oncology (2003)
Constitutive activation of NF‐κB and T‐cell leukemia/lymphoma in Notch3 transgenic mice
Diana Bellavia;Antonio F. Campese;Edoardo Alesse;Alessandra Vacca.
The EMBO Journal (2000)
Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements.
Alessandra Vacca;Maria P. Felli;Antonietta R. Farina;Stefano Martinotti.
Journal of Experimental Medicine (1992)
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis
Cristina Cerboni;Alessandra Zingoni;Marco Cippitelli;Mario Piccoli.
Blood (2007)
Brain White-Matter Volume Loss and Glucose Hypometabolism Precede the Clinical Symptoms of Huntington's Disease
Andrea Ciarmiello;Milena Cannella;Secondo Lastoria;Maria Simonelli.
The Journal of Nuclear Medicine (2006)
Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family.
C. Marchese;J. Rubin;D. Ron;A. Faggioni.
Journal of Cellular Physiology (1990)
HE4: a new potential early biomarker for the recurrence of ovarian cancer
Emanuela Anastasi;Giulia Giovanna Marchei;Valentina Viggiani;Giuseppina Gennarini.
Tumor Biology (2010)
Combined expression of pTα and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis
Diana Bellavia;Antonio F. Campese;Saula Checquolo;Anna Balestri.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Expression pattern of Notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand–receptor interactions in intrathymic T cell development
Maria Pia Felli;Marella Maroder;Thimios A. Mitsiadis;Antonio F. Campese.
International Immunology (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Sapienza University of Rome
Sapienza University of Rome
Sapienza University of Rome
Sapienza University of Rome
University of Perugia
Catholic University of the Sacred Heart
Sapienza University of Rome
University of Rome Tor Vergata
National Taiwan University of Science and Technology
Centre national de la recherche scientifique, CNRS
Boğaziçi University
Wuhan University
Oracle (United States)
University of Florida
University of York
University of Sydney
University of Calgary
National Institutes of Health
University of Toronto
Ghent University
University of Leeds
University of Nottingham
University of Padua
Yale University